Abstract
BackgroundThe EULAR research agenda states that new biomarkers are needed to stratify patients and to predict therapeutic response or lack of response in rheumatoid arthritis. Currently, IgG anti-citrullinated protein antibody...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have